Table 1.
Characteristics of patients with locally advanced periocular biopsy-proven SCC with orbital invasion.
| Pt. no. | Age (y)/sex | Other tumours | Primary site of cutaneous SCC | Previous SCC treatment: Systemic/RT | PNI | T/N/M stage | Tx time (d) | Tx response | ECOG score | Other Tx | OE | Died | Cause of death |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 65/M | Periocular | No/no | No | 4/1/0 | 422 | CR | 1 | No | No | |||
| 2 | 61/M | BCC | Periocular | Yes/yes | No | 4/0/1 | 460 | CR | 2 | No | No | ||
| 3 | 68M | BCC | Periocular | Yes/yes | Yes | 4/1/0 | 156 | CR | 2 | No | Yes | ||
| 4 | 83/F | BCC | Nose | No/yes | Yes | 4/1/0 | 21 | PR | 4 | No | Yes | Cardiac event | |
| 5 | 94/F | Periocular | No/yes | No | 4/0/0 | 21 | NE | 4 | No | No | Myocarditis | ||
| 6 | 82/M | Stomach adenocar-cinoma | Periocular | Yes/yes | No | 4/0/0 | 246 | SD | 2 | Chemo | No | No | |
| 7 | 64/F | Forearm melanoma | Periocular | Yes/yes | No | 4/1/1 | 105 | PD | 1 | No | No | ||
| 8 | 68/F | Forehead | Yes/yes | Yes | 4/0/0 | 531 | CR | 1 | No | No | |||
| 9 | 82/M | SCC other | Periocular | No/no | No | 4/0/0 | 252 | CR | 1 | Chemo | No | No | |
| 10 | 76/M | Periocular | No/no | No | 4/0/0 | 126 | CR | 1 | No | No | |||
| 11 | 90/M | Periocular | No/no | No | 4/0/1 | 146 | CR | 4 | No | Yes | Sepsis | ||
| 12 | 89/M | Periocular | No/no | No | 4/0/1 | 209 | PD | 4 | No | Yes | |||
| 13 | 65/F | Forehead | No/no | No | 4/1/0 | 135 | PR | 1 | No | No |
BCC basal cell carcinoma, SCC squamous cell carcinoma, PNI perineural invasion, Tx treatment, ECOG Eastern Cooperative Oncology Group, OE ocular exenteration, RT radiotherapy, Chemo chemotherapy.